GAS5 and neutropenia: In conclusion, in this two stage discovery-validation study, we highlighted two potential functional locus, GAS5 rs2067079 and rs6790 for chemoradiotherapy induced severe myelosuppression and severe neutropenia among NPC patients for the first time.